Clinuvel Pharmaceuticals Limited (CUVL)
NMS · Healthcare · Biotechnology
$5.03
-1.76%
Closing price as of 2026-10-22 · Source: TEK2day Finance
1-Year Price History
-33.0% over period
Key Metrics
Annual Financials
| Metric | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|
| Revenue | 78.3M | 88.2M | 95.0M | 94.0M |
| Gross Profit | 69.5M | 78.1M | 79.1M | 78.2M |
| Operating Income | 44.1M | 48.0M | 45.7M | 39.5M |
| Net Income | 30.6M | 35.6M | 36.2M | 33.9M |
| Diluted EPS | $0.59 | $0.70 | $0.72 | $0.67 |
Want live quotes, estimates, SEC filings, and CEO analytics for CUVL?
The free TEK2day terminal runs in your browser — type /CUVL to get started.
Open CUVL in the Terminal →